Health Care & Insurance  November 20, 2018

Brava Diagnostics raises $4 million to bring acute care tests to clinical trial

BOULDER — Brava Diagnostics Inc., a Boulder biotech company, has raised $4 million in capital.

The company is raising the funds through an equity offering, according to a Form D filed with the U.S. Securities and Exchange Commission on Nov. 15.

Byron Hewett, CEO of Brava, said the company specializes in acute care diagnostics, such for the diagnosis and management of heart attacks. Brava is developing its diagnostic tests using a platform developed by MBio Diagnostics — another Boulder-based company.

Hewett said the $4 million the company has raised is going toward finishing…

Related Posts

A Maryland native, Lucas has worked at news agencies from Wyoming to South Carolina before putting roots down in Colorado.
Sign up for BizWest Daily Alerts
Closing in 8 seconds...